https://medlineplus.gov/ency/article/000539.htm
Hemophilia B: MedlinePlus Medical Encyclopedia
Hemophilia B is a hereditary bleeding disorder caused by a lack of blood clotting factor IX. Without enough factor IX, the blood cannot clot properly to...
hemophilia bmedlineplusmedicalencyclopedia
https://health.economictimes.indiatimes.com/news/pharma/pfizers-hemophilia-b-gene-therapy-succeeds-in-late-stage-study/96601269
Pfizer S: Pfizer's hemophilia B gene therapy succeeds in late-stage study, ETHealthworld
Pfizer S: Pfizer's therapy, fidanacogene elaparvovec, is designed to help patients produce factor IX themselves after a one-time treatment, as opposed to...
hemophilia bgene therapy
https://www.hemophiliab.com/
Hemophilia B The Pursuit of Control | Welcome
hemophilia bthe pursuitcontrolwelcome
https://pubmed.ncbi.nlm.nih.gov/8307821/
Factor IX deficiency (hemophilia B) in a family of British shorthair cats
This report describes the clinical findings of a British shorthair cat with hemophilia B, the family pedigree surrounding the case, and how this disorder can...
factor ixhemophilia b
https://scholars.uky.edu/en/projects/agt4hb-viral-vector-for-gene-transfer-in-subjects-with-hemophilia-2/
AGT4HB - Viral Vector for Gene Transfer in Subjects with Hemophilia B - University of Kentucky
https://www.pfizer.com/news/press-release/press-release-detail/fda-and-ema-accept-marstacimab-regulatory-submissions
FDA and EMA Accept Marstacimab Regulatory Submissions for the Treatment of Hemophilia A and B |...
Submissions based on positive data from the Phase 3 BASIS trial, which were presented this past weekend at the American Society of Hematology (ASH) Annual...